APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Living Biological Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Living Biological Drugs Industry Growth and Trends Forecast to 2032

Report ID 174178430116 January 2026122 pages

Choose your research edition.

Industry ResearchLiving Biological Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Living Biological Drugs Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Living Biological Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Living Biological Drugs Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Living Biological Drugs Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

According to APO Research, the global Living Biological Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Living Biological Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Living Biological Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Living Biological Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Living Biological Drugs market include Ardeypharman, Miyarisan Pharmaceutical, Ferring Pharmaceuticals, Seres Therapeutics, Infant Bacterial Therapeutics, Osel, Takeda, AOBiome and Synlogic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Living Biological Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Living Biological Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Living Biological Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Living Biological Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Living Biological Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Living Biological Drugs Market by Company

Ardeypharman

Miyarisan Pharmaceutical

Ferring Pharmaceuticals

Seres Therapeutics

Infant Bacterial Therapeutics

Osel

Takeda

AOBiome

Synlogic

Finch Therapeutics

Capsugel

Jeneil Biotech

UAS Labs

Biose

Cerbios-Pharma

Inpac Probiotics

NIZO

Winclove Probiotics

BJP Laboratories

Luina Bio

List Labs

MatriSys Bioscience

Living Biological Drugs Segment by Type

Single Strain

Multi Strain

Co-Culture

Living Biological Drugs Segment by Application

Digestive System

Urinary System

Skin System

Living Biological Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Living Biological Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Living Biological Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Living Biological Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Living Biological Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Living Biological Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Living Biological Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Living Biological Drugs Market Share by Region (2021-2026) Table 4. Global Living Biological Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Living Biological Drugs Market Share by Region (2027-2032) Table 6. Global Living Biological Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Living Biological Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Living Biological Drugs Market Size Share by Type (2021-2026) Table 9. Global Living Biological Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Living Biological Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Living Biological Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Living Biological Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Living Biological Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Living Biological Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Living Biological Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Living Biological Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Living Biological Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Living Biological Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Living Biological Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Living Biological Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Living Biological Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Living Biological Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Living Biological Drugs Market Size Share by Application (2021-2026) Table 24. Global Living Biological Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Living Biological Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Living Biological Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Living Biological Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Living Biological Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Living Biological Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Living Biological Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Living Biological Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Living Biological Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Living Biological Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Living Biological Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Living Biological Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Living Biological Drugs Industry Trends Table 37. Living Biological Drugs Industry Drivers Table 38. Living Biological Drugs Industry Opportunities and Challenges Table 39. Living Biological Drugs Industry Restraints Table 40. Global Living Biological Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Living Biological Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Living Biological Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Living Biological Drugs Key Company Headquarters & Area Served Table 44. Global Living Biological Drugs Company, Product Type & Application Table 45. Global Living Biological Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Living Biological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Ardeypharman Company Information Table 49. Ardeypharman Business Overview Table 50. Ardeypharman Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Ardeypharman Living Biological Drugs Product Portfolio Table 52. Ardeypharman Recent Development Table 53. Miyarisan Pharmaceutical Company Information Table 54. Miyarisan Pharmaceutical Business Overview Table 55. Miyarisan Pharmaceutical Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Miyarisan Pharmaceutical Living Biological Drugs Product Portfolio Table 57. Miyarisan Pharmaceutical Recent Development Table 58. Ferring Pharmaceuticals Company Information Table 59. Ferring Pharmaceuticals Business Overview Table 60. Ferring Pharmaceuticals Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Ferring Pharmaceuticals Living Biological Drugs Product Portfolio Table 62. Ferring Pharmaceuticals Recent Development Table 63. Seres Therapeutics Company Information Table 64. Seres Therapeutics Business Overview Table 65. Seres Therapeutics Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Seres Therapeutics Living Biological Drugs Product Portfolio Table 67. Seres Therapeutics Recent Development Table 68. Infant Bacterial Therapeutics Company Information Table 69. Infant Bacterial Therapeutics Business Overview Table 70. Infant Bacterial Therapeutics Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Infant Bacterial Therapeutics Living Biological Drugs Product Portfolio Table 72. Infant Bacterial Therapeutics Recent Development Table 73. Osel Company Information Table 74. Osel Business Overview Table 75. Osel Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Osel Living Biological Drugs Product Portfolio Table 77. Osel Recent Development Table 78. Takeda Company Information Table 79. Takeda Business Overview Table 80. Takeda Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Takeda Living Biological Drugs Product Portfolio Table 82. Takeda Recent Development Table 83. AOBiome Company Information Table 84. AOBiome Business Overview Table 85. AOBiome Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. AOBiome Living Biological Drugs Product Portfolio Table 87. AOBiome Recent Development Table 88. Synlogic Company Information Table 89. Synlogic Business Overview Table 90. Synlogic Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Synlogic Living Biological Drugs Product Portfolio Table 92. Synlogic Recent Development Table 93. Finch Therapeutics Company Information Table 94. Finch Therapeutics Business Overview Table 95. Finch Therapeutics Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Finch Therapeutics Living Biological Drugs Product Portfolio Table 97. Finch Therapeutics Recent Development Table 98. Capsugel Company Information Table 99. Capsugel Business Overview Table 100. Capsugel Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Capsugel Living Biological Drugs Product Portfolio Table 102. Capsugel Recent Development Table 103. Jeneil Biotech Company Information Table 104. Jeneil Biotech Business Overview Table 105. Jeneil Biotech Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Jeneil Biotech Living Biological Drugs Product Portfolio Table 107. Jeneil Biotech Recent Development Table 108. UAS Labs Company Information Table 109. UAS Labs Business Overview Table 110. UAS Labs Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. UAS Labs Living Biological Drugs Product Portfolio Table 112. UAS Labs Recent Development Table 113. Biose Company Information Table 114. Biose Business Overview Table 115. Biose Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Biose Living Biological Drugs Product Portfolio Table 117. Biose Recent Development Table 118. Cerbios-Pharma Company Information Table 119. Cerbios-Pharma Business Overview Table 120. Cerbios-Pharma Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Cerbios-Pharma Living Biological Drugs Product Portfolio Table 122. Cerbios-Pharma Recent Development Table 123. Inpac Probiotics Company Information Table 124. Inpac Probiotics Business Overview Table 125. Inpac Probiotics Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Inpac Probiotics Living Biological Drugs Product Portfolio Table 127. Inpac Probiotics Recent Development Table 128. NIZO Company Information Table 129. NIZO Business Overview Table 130. NIZO Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. NIZO Living Biological Drugs Product Portfolio Table 132. NIZO Recent Development Table 133. Winclove Probiotics Company Information Table 134. Winclove Probiotics Business Overview Table 135. Winclove Probiotics Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Winclove Probiotics Living Biological Drugs Product Portfolio Table 137. Winclove Probiotics Recent Development Table 138. BJP Laboratories Company Information Table 139. BJP Laboratories Business Overview Table 140. BJP Laboratories Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. BJP Laboratories Living Biological Drugs Product Portfolio Table 142. BJP Laboratories Recent Development Table 143. Luina Bio Company Information Table 144. Luina Bio Business Overview Table 145. Luina Bio Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Luina Bio Living Biological Drugs Product Portfolio Table 147. Luina Bio Recent Development Table 148. List Labs Company Information Table 149. List Labs Business Overview Table 150. List Labs Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. List Labs Living Biological Drugs Product Portfolio Table 152. List Labs Recent Development Table 153. MatriSys Bioscience Company Information Table 154. MatriSys Bioscience Business Overview Table 155. MatriSys Bioscience Living Biological Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. MatriSys Bioscience Living Biological Drugs Product Portfolio Table 157. MatriSys Bioscience Recent Development Table 158. North America Living Biological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Living Biological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Living Biological Drugs Market Share by Country (2021-2026) Table 161. North America Living Biological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Living Biological Drugs Market Share Forecast by Country (2027-2032) Table 163. Europe Living Biological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Living Biological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Living Biological Drugs Market Share by Country (2021-2026) Table 166. Europe Living Biological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Living Biological Drugs Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Living Biological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Living Biological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Living Biological Drugs Market Share by Country (2021-2026) Table 171. Asia-Pacific Living Biological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Living Biological Drugs Market Share Forecast by Country (2027-2032) Table 173. Latin America Living Biological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Living Biological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Living Biological Drugs Market Share by Country (2021-2026) Table 176. Latin America Living Biological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Living Biological Drugs Market Share Forecast by Country (2027-2032) Table 178. Middle East & Africa Living Biological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East & Africa Living Biological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East & Africa Living Biological Drugs Market Share by Country (2021-2026) Table 181. Middle East & Africa Living Biological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East & Africa Living Biological Drugs Market Share Forecast by Country (2027-2032) Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Living Biological Drugs Product Image Figure 3. Global Living Biological Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Living Biological Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Living Biological Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Living Biological Drugs Market Share by Region (2021-2032) Figure 7. North America Living Biological Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Living Biological Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Living Biological Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Living Biological Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Living Biological Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Single Strain Image Figure 13. Global Single Strain Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Multi Strain Image Figure 15. Global Multi Strain Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Co-Culture Image Figure 17. Global Co-Culture Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Living Biological Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Living Biological Drugs Market Share by Type 2025 VS 2032 Figure 20. North America Living Biological Drugs Market Size Share by Type (2021-2032) Figure 21. Europe Living Biological Drugs Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Living Biological Drugs Market Size Share by Type (2021-2032) Figure 23. Latin America Living Biological Drugs Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Living Biological Drugs Market Size Share by Type (2021-2032) Figure 25. Digestive System Image Figure 26. Global Digestive System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Urinary System Image Figure 28. Global Urinary System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Skin System Image Figure 30. Global Skin System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Living Biological Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Living Biological Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Living Biological Drugs Market Size Share by Application (2021-2032) Figure 34. Europe Living Biological Drugs Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Living Biological Drugs Market Size Share by Application (2021-2032) Figure 36. Latin America Living Biological Drugs Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Living Biological Drugs Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Living Biological Drugs Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Living Biological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Living Biological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Living Biological Drugs Market Share by Country (2021-2032) Figure 43. Europe Living Biological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Living Biological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Living Biological Drugs Market Share by Country (2021-2032) Figure 46. Asia-Pacific Living Biological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Living Biological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Living Biological Drugs Market Share by Country (2021-2032) Figure 49. Latin America Living Biological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Living Biological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Living Biological Drugs Market Share by Country (2021-2032) Figure 52. Middle East & Africa Living Biological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Living Biological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Living Biological Drugs Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Single Strain
  • Multi Strain
  • Co-Culture
Applications
  • Digestive System
  • Urinary System
  • Skin System
Companies covered
  • Ardeypharman
  • Miyarisan Pharmaceutical
  • Ferring Pharmaceuticals
  • Seres Therapeutics
  • Infant Bacterial Therapeutics
  • Osel
  • Takeda
  • AOBiome
  • Synlogic
  • Finch Therapeutics
  • Capsugel
  • Jeneil Biotech
  • UAS Labs
  • Biose
  • Cerbios-Pharma
  • Inpac Probiotics
  • NIZO
  • Winclove Probiotics
  • BJP Laboratories
  • Luina Bio
  • List Labs
  • MatriSys Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Living Biological Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Living Biological Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Living Biological Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Living Biological Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Living Biological Drugs Market Size (2021-2032)
  8. 1.5.1 North America Living Biological Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Living Biological Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Living Biological Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Living Biological Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Living Biological Drugs Market Size Growth Rate (2021-2032)
2 Living Biological Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Single Strain
  3. 2.1.2 Multi Strain
  4. 2.1.3 Co-Culture
  5. 2.2 Global Living Biological Drugs Market Size by Type
  6. 2.2.1 Global Living Biological Drugs Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Living Biological Drugs Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Living Biological Drugs Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Living Biological Drugs Market Size by Regions
  10. 2.3.1 North America Living Biological Drugs Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Living Biological Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Living Biological Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Living Biological Drugs Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Living Biological Drugs Market Size Breakdown by Type (2021-2026)
3 Living Biological Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Digestive System
  3. 3.1.2 Urinary System
  4. 3.1.3 Skin System
  5. 3.2 Global Living Biological Drugs Market Size by Application
  6. 3.2.1 Global Living Biological Drugs Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Living Biological Drugs Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Living Biological Drugs Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Living Biological Drugs Market Size by Regions
  10. 3.3.1 North America Living Biological Drugs Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Living Biological Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Living Biological Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Living Biological Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Living Biological Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Living Biological Drugs Industry Trends
  2. 4.2 Living Biological Drugs Industry Drivers
  3. 4.3 Living Biological Drugs Industry Opportunities and Challenges
  4. 4.4 Living Biological Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Living Biological Drugs Revenue (2021-2026)
  2. 5.2 Global Living Biological Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Living Biological Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Living Biological Drugs Company, Product Type & Application
  5. 5.5 Global Living Biological Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Living Biological Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Living Biological Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Living Biological Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Ardeypharman
  2. 6.1.1 Ardeypharman Company Information
  3. 6.1.2 Ardeypharman Business Overview
  4. 6.1.3 Ardeypharman Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Ardeypharman Living Biological Drugs Product Portfolio
  6. 6.1.5 Ardeypharman Recent Developments
  7. 6.2 Miyarisan Pharmaceutical
  8. 6.2.1 Miyarisan Pharmaceutical Company Information
  9. 6.2.2 Miyarisan Pharmaceutical Business Overview
  10. 6.2.3 Miyarisan Pharmaceutical Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Miyarisan Pharmaceutical Living Biological Drugs Product Portfolio
  12. 6.2.5 Miyarisan Pharmaceutical Recent Developments
  13. 6.3 Ferring Pharmaceuticals
  14. 6.3.1 Ferring Pharmaceuticals Company Information
  15. 6.3.2 Ferring Pharmaceuticals Business Overview
  16. 6.3.3 Ferring Pharmaceuticals Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Ferring Pharmaceuticals Living Biological Drugs Product Portfolio
  18. 6.3.5 Ferring Pharmaceuticals Recent Developments
  19. 6.4 Seres Therapeutics
  20. 6.4.1 Seres Therapeutics Company Information
  21. 6.4.2 Seres Therapeutics Business Overview
  22. 6.4.3 Seres Therapeutics Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Seres Therapeutics Living Biological Drugs Product Portfolio
  24. 6.4.5 Seres Therapeutics Recent Developments
  25. 6.5 Infant Bacterial Therapeutics
  26. 6.5.1 Infant Bacterial Therapeutics Company Information
  27. 6.5.2 Infant Bacterial Therapeutics Business Overview
  28. 6.5.3 Infant Bacterial Therapeutics Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Infant Bacterial Therapeutics Living Biological Drugs Product Portfolio
  30. 6.5.5 Infant Bacterial Therapeutics Recent Developments
  31. 6.6 Osel
  32. 6.6.1 Osel Company Information
  33. 6.6.2 Osel Business Overview
  34. 6.6.3 Osel Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Osel Living Biological Drugs Product Portfolio
  36. 6.6.5 Osel Recent Developments
  37. 6.7 Takeda
  38. 6.7.1 Takeda Company Information
  39. 6.7.2 Takeda Business Overview
  40. 6.7.3 Takeda Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Takeda Living Biological Drugs Product Portfolio
  42. 6.7.5 Takeda Recent Developments
  43. 6.8 AOBiome
  44. 6.8.1 AOBiome Company Information
  45. 6.8.2 AOBiome Business Overview
  46. 6.8.3 AOBiome Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 AOBiome Living Biological Drugs Product Portfolio
  48. 6.8.5 AOBiome Recent Developments
  49. 6.9 Synlogic
  50. 6.9.1 Synlogic Company Information
  51. 6.9.2 Synlogic Business Overview
  52. 6.9.3 Synlogic Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Synlogic Living Biological Drugs Product Portfolio
  54. 6.9.5 Synlogic Recent Developments
  55. 6.10 Finch Therapeutics
  56. 6.10.1 Finch Therapeutics Company Information
  57. 6.10.2 Finch Therapeutics Business Overview
  58. 6.10.3 Finch Therapeutics Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Finch Therapeutics Living Biological Drugs Product Portfolio
  60. 6.10.5 Finch Therapeutics Recent Developments
  61. 6.11 Capsugel
  62. 6.11.1 Capsugel Company Information
  63. 6.11.2 Capsugel Business Overview
  64. 6.11.3 Capsugel Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Capsugel Living Biological Drugs Product Portfolio
  66. 6.11.5 Capsugel Recent Developments
  67. 6.12 Jeneil Biotech
  68. 6.12.1 Jeneil Biotech Company Information
  69. 6.12.2 Jeneil Biotech Business Overview
  70. 6.12.3 Jeneil Biotech Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Jeneil Biotech Living Biological Drugs Product Portfolio
  72. 6.12.5 Jeneil Biotech Recent Developments
  73. 6.13 UAS Labs
  74. 6.13.1 UAS Labs Company Information
  75. 6.13.2 UAS Labs Business Overview
  76. 6.13.3 UAS Labs Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 UAS Labs Living Biological Drugs Product Portfolio
  78. 6.13.5 UAS Labs Recent Developments
  79. 6.14 Biose
  80. 6.14.1 Biose Company Information
  81. 6.14.2 Biose Business Overview
  82. 6.14.3 Biose Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Biose Living Biological Drugs Product Portfolio
  84. 6.14.5 Biose Recent Developments
  85. 6.15 Cerbios-Pharma
  86. 6.15.1 Cerbios-Pharma Company Information
  87. 6.15.2 Cerbios-Pharma Business Overview
  88. 6.15.3 Cerbios-Pharma Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Cerbios-Pharma Living Biological Drugs Product Portfolio
  90. 6.15.5 Cerbios-Pharma Recent Developments
  91. 6.16 Inpac Probiotics
  92. 6.16.1 Inpac Probiotics Company Information
  93. 6.16.2 Inpac Probiotics Business Overview
  94. 6.16.3 Inpac Probiotics Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Inpac Probiotics Living Biological Drugs Product Portfolio
  96. 6.16.5 Inpac Probiotics Recent Developments
  97. 6.17 NIZO
  98. 6.17.1 NIZO Company Information
  99. 6.17.2 NIZO Business Overview
  100. 6.17.3 NIZO Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 NIZO Living Biological Drugs Product Portfolio
  102. 6.17.5 NIZO Recent Developments
  103. 6.18 Winclove Probiotics
  104. 6.18.1 Winclove Probiotics Company Information
  105. 6.18.2 Winclove Probiotics Business Overview
  106. 6.18.3 Winclove Probiotics Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Winclove Probiotics Living Biological Drugs Product Portfolio
  108. 6.18.5 Winclove Probiotics Recent Developments
  109. 6.19 BJP Laboratories
  110. 6.19.1 BJP Laboratories Company Information
  111. 6.19.2 BJP Laboratories Business Overview
  112. 6.19.3 BJP Laboratories Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 BJP Laboratories Living Biological Drugs Product Portfolio
  114. 6.19.5 BJP Laboratories Recent Developments
  115. 6.20 Luina Bio
  116. 6.20.1 Luina Bio Company Information
  117. 6.20.2 Luina Bio Business Overview
  118. 6.20.3 Luina Bio Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Luina Bio Living Biological Drugs Product Portfolio
  120. 6.20.5 Luina Bio Recent Developments
  121. 6.21 List Labs
  122. 6.21.1 List Labs Company Information
  123. 6.21.2 List Labs Business Overview
  124. 6.21.3 List Labs Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 List Labs Living Biological Drugs Product Portfolio
  126. 6.21.5 List Labs Recent Developments
  127. 6.22 MatriSys Bioscience
  128. 6.22.1 MatriSys Bioscience Company Information
  129. 6.22.2 MatriSys Bioscience Business Overview
  130. 6.22.3 MatriSys Bioscience Living Biological Drugs Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 MatriSys Bioscience Living Biological Drugs Product Portfolio
  132. 6.22.5 MatriSys Bioscience Recent Developments
7 North America
  1. 7.1 North America Living Biological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Living Biological Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Living Biological Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Living Biological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Living Biological Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Living Biological Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Living Biological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Living Biological Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Living Biological Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Living Biological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Living Biological Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Living Biological Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Living Biological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Living Biological Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Living Biological Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst